Patents by Inventor Roger T. Coleman

Roger T. Coleman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating pancreatitis
    Patent number: 9090687
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: July 28, 2015
    Assignee: Incyte Corporation
    Inventors: Roger T. Coleman, Olga Bandman, Craig G. Wilde
  • METHODS OF TREATING AND DIAGNOSING PANCREATITIS
    Publication number: 20140227275
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
    Type: Application
    Filed: December 11, 2013
    Publication date: August 14, 2014
    Applicant: INCYTE CORPORATION
    Inventors: Roger T. COLEMAN, Olga Bandman, Craig G. Wilde
  • Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodies
    Patent number: 8617551
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: December 31, 2013
    Assignee: Incyte Corporation
    Inventors: Roger T. Coleman, Olga Bandman, Craig G. Wilde
  • Chemokine panec-1 antibodies
    Patent number: 7803373
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
    Type: Grant
    Filed: May 20, 2008
    Date of Patent: September 28, 2010
    Assignee: Incyte Pharmaceuticals, Inc.
    Inventors: Roger T. Coleman, Olga Bandman, Craig G. Wilde
  • Chemokine PANEC-2 polypeptides and compositions and methods related thereto
    Patent number: 7396652
    Abstract: The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
    Type: Grant
    Filed: November 27, 2006
    Date of Patent: July 8, 2008
    Assignee: INCYTE Corporation
    Inventors: Roger T. Coleman, Olga Bandman, Craig G. Wilde
  • Antibodies specifically binding PDE8A and PDE8B
    Publication number: 20030139578
    Abstract: The invention provides a antibody that specifically binds human PDE8s and is used to diagnose, stage and treat prostate cancer.
    Type: Application
    Filed: October 15, 2002
    Publication date: July 24, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Janice K. Au-Young, Benjamin G. Cocks, Roger T. Coleman, Jeffrey J. Seilhamer, Douglas A. Fisher